Company Filing History:
Years Active: 1998-1999
Title: Innovations by Amin Abujoub in Vaccine Development
Introduction
Amin Abujoub is a notable inventor based in East Lansing, MI (US), recognized for his contributions to the field of vaccine development. He holds a total of 4 patents, focusing primarily on sustainable cell lines for the production of vaccines against Marek's disease in poultry.
Latest Patents
His latest patents include a sustainable cell line for the production of Marek's disease vaccines. This invention describes chicken cell lines that contain Marek's Disease Virus (MDV), which can present as either a non-lytic or a lytic infection. The methods and vaccines against avian MDV prepared from these cell lines are also detailed. Another significant patent is for a sustainable chick cell line infected with Marek's disease virus. This cell line is derived from chick embryo cells that are chicken helper factor (Chf) negative and have been treated with N-methyl-N-nitro-N-nitrosoguansidine (MNNG). It has been converted with the MDV, which is capable of infecting avians in vivo. This cell line is particularly useful for vaccine production and for studying the characteristics of MDV under various conditions.
Career Highlights
Amin Abujoub is affiliated with Michigan State University, where he continues to advance research in vaccine development. His work has significant implications for the poultry industry, particularly in combating Marek's disease, which poses a serious threat to avian health.
Collaborations
He collaborates with esteemed colleagues such as Paul M. Coussens and John David Reilly, contributing to a robust research environment focused on innovative solutions in veterinary medicine.
Conclusion
Amin Abujoub's innovative work in developing sustainable cell lines for vaccine production showcases his commitment to advancing veterinary medicine. His contributions are vital for improving the health and welfare of poultry, making a significant impact in the field.